Terns Pharmaceuticals, Inc. (TERN) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Terns Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Terns Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $59.6 M, a 41.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $59.6 M +$17.4 M +41.3% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $42.2 M +$13.4 M +46.3% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $28.8 M +$27.4 M +1916% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $1.43 M Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.